[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,6,9,9a,10,11,13,14,14a,14b-decahydro-5-methyl-6-methylene-,(3Z,9aS,14aR,14bR)- (570-18-3)

Identification
Name:	[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,6,9,9a,10,11,13,14,14a,14b-decahydro-5-methyl-6-methylene-,(3Z,9aS,14aR,14bR)-
Synonyms:	Mikanoidine(6CI); Senecionan-11,16-dione, 12,13,14,18-tetradehydro-1,2-dihydro-, (1a)-
CAS:	570-18-3
Molecular Formula:	C₁₈H₂₃NO₄
Molecular Structure:
Properties
Safety Data

Other Product

[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-methyl-5-methylene-,(3Z,6R,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,6-(acetyloxy)-3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-methyl-5-methylene-,(3Z,6R,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methylene-,(3Z,6S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methylene-,12-oxide, (3Z,6S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methyl-,(3Z,5R,6S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methyl-,(3E,5R,6S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methyl-, (3E,5S,6S,14aR,14bR)- (9CI)
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-,12-oxide, (3Z,5R,6R,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-,(3Z,5R,6R,14aR,14bR)-
Spiro[[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3(2H),2'-oxirane]-2,7(4H)-dione,5,6,9,11,13,14,14a,14b-octahydro-6-hydroxy-3',6-dimethyl-5-methylene-,(2'S,3'S,6R,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3-ethylidenedodecahydro-6,10- dihydroxy-6-(hydroxymethyl)-5-methyl-,(3Z,- 5R,6S,9aS,10S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14bdecahydro- 6-hydroxy-5,6-dimethyl-,(3Z,5S,- 6S,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3-ethylidenedodecahydro-6-hydroxy-5,- 6-dimethyl-,(3E,5R,6R,9aS,14aR,14bR)-
Spiro[[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3(2H),2'-oxirane]-2,7(4H)-dione,5,6,9,11,13,14,14a,14b-octahydro-6-hydroxy-3',5,6-trimethyl-,(2'S,3'S,5R,6R,14aR,14bR)-
Spiro[[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3(2H),2'-oxirane]-2,7(4H)-dione,5,6,9,11,13,14,14a,14b-octahydro-6-hydroxy-4,5,6-trimethyl-,(2'S,4R,5R,6S,14aR,14bR)- (9CI)
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,6-(acetyloxy)-3-ethyl-3,4,5,6,9,11,13,14,14a,14b-decahydro-3-hydroxy-5,6-dimethyl-,(3R,5R,6S,14aR,14bR)-
Adenosine 5'-(tetrahydrogen triphosphate),compounds,tetrasodium salt,mixt. with (3Z,5R,6R,9aS,14aR,14bR)-3-ethylidenedodecahydro- 6-hydroxy-5,6-dimethyl[1,6]- dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) and heparin
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7- dione,3,4,5,6,9,11,13,14,14a,14b-decahydro-6- hydroxy-2-(2-hydroxyethylidene)-5,6- dimethyl-,(3E,5R,6R,14aR,14bR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,13,14,14a-octahydro-6-hydroxy-5,6-dimethyl-,(3Z,5R,6R,14aR)-
[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6,14-dihydroxy-5,6-dimethyl-,(3Z,5R,6R,14R,14aS,14bR)-